Read the quarter in context.
A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹3,662 Cr
verified against source
Revenue YoY
10%
reported change
EBITDA
Pending
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
GCPL reported a mixed Q1 FY26. Consolidated revenue grew 10% YoY with 8% underlying volume growth, but EBITDA declined 3% YoY. India standalone delivered mid-teens volume growth excluding soaps, driven by household insecticides (high single-digit volume growth) and strong performance in air fresheners and laundry liquids. Soap volumes were impacted by grammage cuts and a poor May season. Indonesia faced macro headwinds and competitive pricing, while Africa grew sales 30% YoY. Management expects sequential margin improvement in H2 FY26, with standalone EBITDA margins below normative range in H1 but recovering in H2. Full-year guidance: mid-to-high single-digit EVG for standalone, high single-digit consolidated revenue growth, and double-digit consolidated EBITDA growth. Key risk: sustained competitive pressure in Indonesia could delay margin recovery.
Colored figures show movement against the previous available record.
Guidance to track
- H1 FY26 standalone EBITDA margins will be below normative range, but expected to improve in H2 as palm oil benefits and cost savings kick in.
- Management expects high single-digit consolidated INR revenue growth for FY26.
- Management expects double-digit consolidated EBITDA growth for FY26.
- Underlying volume growth for standalone business expected to be mid-to-high single digit for the full year.
Risks flagged
- Indonesia business impacted by macro headwinds and competitive pricing; management expects transitory but uncertainty remains.
- Grammage cuts and poor season led to soap volume decline; recovery depends on base effects and consumer behavior.
- Palm oil prices have moderated but recently rallied 10%; benefits may be delayed if prices stay elevated.
- Competitors may reverse-engineer new molecule or copy messaging, potentially reducing GCPL's differentiation.
Key quotes
- This is the first quarter really in a regular quarter in a decade that overall HI shares we've gained, which is a very, very hard thing.
- Our objective is always to defend our shares and to grow our shares. That is number one priority in a macro that's poor.
- I have a feeling that this is a bit of a temporary drop and it should come back in the next two months.
Research modules
